COVID-19 Corona Virus South African Resource Portal - sacoronavirus.co.za

Ascendis Health

ASCENDIS HEALTH’S INTERNATIONAL GROWTH OFFSET BY WEAKER DOMESTIC PERFORMANCE

Johannesburg – South African-based international health and wellness business Ascendis Health today reported a 3% increase in revenue to R4 billion for the six months to December 2018 while normalised operating profit was 2% lower at R619 million.

March 18, 2019

International revenue rose by 7% to R2 billion and accounts for 50% of the group’s total sales. The tough consumer environment and weak sentiment in South Africa resulted in domestic revenue declining by 1%. The group’s gross margin strengthened by 260 basis points to 44.9%, mainly due to improved raw material pricing through strategic sourcing […]

SALE OF NON CORE ASSETS

Johannesburg – Ascendis Health has concluded a sale agreement of its pharmaceutical manufacturing facility in Isando, Gauteng, to Mylan, one of the world’s leading pharmaceutical companies, for R130 million.

December 20, 2018

The contemplated sale forms part of Ascendis Health’s non-core asset disposal programme announced earlier this year following management’s strategic business review. Chief executive officer Thomas Thomsen said: “After an extensive evaluation of our pharmaceutical manufacturing requirements we decided to sell the Isando plant owing to its low utilisation and to reduce the complexity of our […]